These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8355033)

  • 1. The clinical cancer researcher--still an embattled species.
    Frei E; Freireich EJ
    J Clin Oncol; 1993 Sep; 11(9):1639-51. PubMed ID: 8355033
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues of sample size in sensitivity and specificity analysis with special reference to oncology.
    Juneja A; Sharma S
    J Cancer Res Ther; 2015; 11(2):482-4. PubMed ID: 26148624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer research funding in Europe low compared with U.S., survey finds.
    Illman J
    J Natl Cancer Inst; 2005 May; 97(10):713-4. PubMed ID: 15900040
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effectiveness research in oncology: the promise, challenges, and opportunities.
    Chen RC
    Semin Radiat Oncol; 2014 Jan; 24(1):1-4. PubMed ID: 24314336
    [No Abstract]   [Full Text] [Related]  

  • 5. NCI Posts New "Provocative Questions".
    Cancer Discov; 2015 Jun; 5(6):569-70. PubMed ID: 25929849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First person profile: Joseph Sparano, MD: A respected physician and researcher, Dr. Sparano led the practice-changing TAILORx clinical trial for breast cancer treatment and is working to close disparities in cancer care.
    Printz C
    Cancer; 2019 Dec; 125(23):4121-4123. PubMed ID: 31725191
    [No Abstract]   [Full Text] [Related]  

  • 7. Academic versus industry-driven research in upper gastrointestinal cancer: sinners and saints.
    Hendlisz A; Charette N; Awada A; Deleporte A
    Curr Opin Oncol; 2013 Jul; 25(4):407-8. PubMed ID: 23673411
    [No Abstract]   [Full Text] [Related]  

  • 8. [Qualitative research and clinical study on cancer].
    Yu H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Feb; 28(2):169-71. PubMed ID: 18386584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A care model for the future: the oncology medical home.
    Eagle D; Sprandio J
    Oncology (Williston Park); 2011 Jun; 25(7):571, 575-6. PubMed ID: 21888254
    [No Abstract]   [Full Text] [Related]  

  • 10. CRUK Invests £15 Million in Research Hubs.
    Cancer Discov; 2015 Sep; 5(9):897-8. PubMed ID: 26201899
    [No Abstract]   [Full Text] [Related]  

  • 11. The strength of European oncology.
    Smyth JF
    Eur J Cancer; 2008 Jan; 44(1):6-7. PubMed ID: 18077154
    [No Abstract]   [Full Text] [Related]  

  • 12. Emphasizing the provocative.
    Rose S
    Cancer Discov; 2012 Nov; 2(11):968. PubMed ID: 23148360
    [No Abstract]   [Full Text] [Related]  

  • 13. CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
    Hammond AL; Waller EK; Finkelstein LB
    J Clin Oncol; 2007 Apr; 25(10):1288; author reply 1288. PubMed ID: 17401022
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal cancer care across the spectrum of life and disease.
    Lyman GH; Hauser RS
    Am J Manag Care; 2008 May; 14(5):262-4. PubMed ID: 18471030
    [No Abstract]   [Full Text] [Related]  

  • 15. Stakeholder perspectives on the use of positron emission tomography in phase III oncology trials in the UK.
    Rojas-Anaya H; Skogen K; Miles KA
    Nucl Med Commun; 2012 Jun; 33(6):626-32. PubMed ID: 22543952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The center responds to the fringe.
    Grunberg SM
    J Clin Oncol; 1993 Sep; 11(9):1837-8. PubMed ID: 7689095
    [No Abstract]   [Full Text] [Related]  

  • 17. Palliative care programs still face obstacles in mainstream cancer care.
    Benowitz S
    J Natl Cancer Inst; 2013 Mar; 105(6):372-4. PubMed ID: 23457209
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
    American Society of Clinical Oncology
    J Oncol Pract; 2014 Jul; 10(4):259-63. PubMed ID: 24737877
    [No Abstract]   [Full Text] [Related]  

  • 19. Researching for-profit research: the obligations of hospital ethicists.
    La Puma J
    Clin Res; 1989 Oct; 37(4):569-73. PubMed ID: 2805589
    [No Abstract]   [Full Text] [Related]  

  • 20. Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
    Ratain MJ; Karrison TG
    Clin Cancer Res; 2007 Feb; 13(3):781-2. PubMed ID: 17289865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.